ConductScience.org, home

Paper3373659

Characterization of antihypertensive therapy by whole-day blood pressure monitoring.

Weber MA and 3 others. JAMA, 1988. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. Papers, record 3373659. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3373659

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of antihypertensive therapy by whole-day blood pressure monitoring.
PubMed
Journal
JAMA
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
6.51
iCite
Revised in PubMed
2016-10-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weber MAM A
2Cheung DGD G
3Graettinger WFW F
4Lipson JLJ L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood Pressure DeterminationMajor topic
DiltiazemMajor topic
HypertensionMajor topic
Adult
Aged
Body Weight
Double-Blind Method
Female
Heart Rate
Humans
Male
Middle Aged
Monitoring, Physiologic

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
24667908An analysis of 24-h ambulatory blood pressure monitoring data using orthonormal polynomials in the linear mixed model.Blood Press Monit2014https://conductscience.org/library/papers/24667908PubMed
17215652Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment.J Clin Hypertens (Greenwich)2007https://conductscience.org/library/papers/17215652PubMed
16596026An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.J Clin Hypertens (Greenwich)2006https://conductscience.org/library/papers/16596026PubMed
15361888Comparing office-based and ambulatory blood pressure monitoring in clinical trials.J Hum Hypertens2005https://conductscience.org/library/papers/15361888PubMed
10981177Treatment of white coat hypertension.Curr Hypertens Rep2000https://conductscience.org/library/papers/10981177PubMed
10155311Defining the patient group for cost-effective withdrawal of antihypertensive therapy.Pharmacoeconomics1995https://conductscience.org/library/papers/10155311PubMed
8443029Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8443029PubMed
8403162Vasodilators during cerebral aneurysm surgery.Can J Anaesth1993https://conductscience.org/library/papers/8403162PubMed
8369596Diltiazem. A review of its pharmacology and therapeutic use in older patients.Drugs Aging1993https://conductscience.org/library/papers/8369596PubMed
7917870Clinical uses of ambulatory blood pressure monitoring.Pediatr Nephrol1994https://conductscience.org/library/papers/7917870PubMed
7894213Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.Clin Investig1994https://conductscience.org/library/papers/7894213PubMed
7512472Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?Drugs1993https://conductscience.org/library/papers/7512472PubMed
2191851Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.Drugs1990https://conductscience.org/library/papers/2191851PubMed
2081142Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2081142PubMed
1888693Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1888693PubMed
1618242Ambulatory blood pressure monitoring for the assessment of nicardipine as a third drug in severe essential hypertension.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1618242PubMed
1352496Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1352496PubMed
1283574Use of ambulatory blood pressure monitoring in the management of antihypertensive therapy.Drugs1992https://conductscience.org/library/papers/1283574PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3373659

GET https://conductscience.org/api/papers/v1/3373659/authors